Mit dem heimultraschallsystem lücken im gesundheitswesen schließen
Pulsenmore (NASDAQ, TASE: PLSM), versteht sich als Vorreiter auf dem Gebiet betreuter Heimultraschallsysteme und möchte den Zugang zur patientinnenzentrierten medizinischen Betreuung Realität werden lassen.
Unsere geschichte
Pulsenmore ist die weltweit erste Plattform für Ultraschalluntersuchungen zu Hause und Telemedizin, die entwickelt wurde, um die Gesundheitsversorgung zugänglicher, intuitiver und konsequent patientenzentriert zu gestalten. Gestützt auf umfangreiche klinische Evidenz und eine großflächige kommerzielle Einführung stärkt Pulsenmore die Kontinuität der Versorgung und ermöglicht ein komfortableres, vernetztes Behandlungserlebnis.
Was macht uns so einzigartig?
Die vorteile von Pulsenmore
Unsere innovative Technologie optimiert die Ressourcenverwaltung. Sie bietet Patientinnen und betreuenden Ärztinnen und Ärzten unübertroffene Flexibilität und Zeitersparnis. Wir helfen, die Arbeitsabläufe „abzuspecken“, optimieren die Kontinuität der vorgeburtlichen Betreuung und steigern die Rundum-Zufriedenheit der Patientinnen.
Eine praktische, sichere und verlässliche Lösung für die Beurteilung des Wohlergehens ungeborenen Lebens per Fernultraschall,
die vom Arzt verordnet wird und die routinemäßigen Ultraschalluntersuchungen ergänzt.
Jeder Scan wird von einem Arzt überprüft und diagnostiziert und kann in der Patientenakte dokumentiert werden.
Bessere Zugang zu ärztlicher Betreuung in abgelegenen ländlichen Gegenden und in modernen „Wohnwüsten“ ohne medizinische Versorgung
Unsere Vision, unsere Mission
Pulsenmore wünscht sich eine Welt, in der Pränatalbetreuung für alle zugänglich, erschwinglich und obendrein nachhaltig ist. Wir revolutionieren die Gesundheit der Mütter, indem wir Fernultraschalltechnologie bieten, die aus dem Komfort des eigenen Haushalts heraus verfügbar ist, herkömmliche Modelle pränataler Betreuung ablöst und die Ergebnisse für Mütter und Babys verbessert.
Kooperationen und auszeichnungen
Am Scheideweg von Telemedizin und Femtech
Pulsenmore steht am Scheideweg zwischen Telemedizin und Femtech. Die von uns realisierten technologischen fortschritte verlagern die Pränatalbetreuung vom krankenhaus in die private Umgebung. Unsere Technologie integriert Telemedizin und Ultraschallbildgebung und bietet eine umfassende Lösung, die die Zugänglichkeit verbessert und die sich entwickelnde Landschaft der Patientenzentrierten Versorgung unterstützt.
Die klinisch validierte Plattform von Pulsenmore wurde erfolgreich implementiert – über 200.000 selbst-scans wurden bereits zu hause durchgeführt und klinisch überprüft!
Die technologie konnte nachweislich die ängste der mütter beschwichtigen, die vorgeburtliche bindung zum kind fördern, klinikbesuche verkürzen und die zufriedenheit der patientinnen steigern.
Pulsenmore revolutioniert die pränatale Betreuung und bietet schwangeren Frauen routinemäßige hochwertige betreuung von zuhause aus.
Ressourcenzentrum
Klinische ressourcen
Nachrichten und Veranstaltungen
Downloads
Klinische ressourcen
This systematic review examined the potential role of tele-ultrasound, handheld, and self-operated ultrasound devices in prenatal care. It assessed how this technology could have enhanced accessibility, accuracy, and convenience for pregnant individuals, especially in remote or underserved areas. The review highlighted Pulsenmore technology as the leading and sole innovation for patient-operated home ultrasound and underscored …
➜
The home ultrasound device was feasible, comparable, and well-correlated with standard IC scans, laying the basis for remote home-based monitoring of follicular development during ovarian stimulation. We believe this also applies to monitoring milder stimulations and even natural cycles.
➜
In this large-scale, retrospective real-world study, we aimed to examine the association between home ultrasound service utilization during pregnancy and adverse pregnancy outcomes.
➜
Remote visits had a success rate of 97.4% (38 of 39), with significantly shorter durations compared with in-clinic visits (median 59.0 min vs. 159.0 min, P
➜
With appropriate patient selection, some older, chronically ill patients can generate high-quality LUS self-images that are non-inferior to those generated by trained physicians using the same device, thereby enabling remote detection of interstitial changes, which may indicate pulmonary congestion. The accuracy of the home ultrasound device was comparable to that of the GS device for …
➜
Pulsenmore ES is a self-scanning ultrasound system for remote fetal assessment. It is composed of a hand-held transducer that serves as a smartphone cradle coupled with an application and clinician’s web-viewer dashboard. Recently, a novel capability was added to the system allowing for offline fetal heart rate (FHR) and maximal vertical pocket (MVP) measurements. The …
➜
Integrating routine home-ultrasound telemedicine visits into prenatal care can significantly reduce maternal anxiety during pregnancy and contribute to greater maternal attachment in individuals with a history of recurrent pregnancy loss. These results emphasize the potential benefits of home ultrasound as a tool to alleviate anxiety, provide a sense of control, and foster a deeper maternal …
➜
A systematic search provided 31 studies. The risk of bias for each study was assessed. Results were analyzed and presented in a narrative overview in four domains: tele‐ultrasound, patient‐operated ultrasound, handheld devices and low‐ and middle‐income countries .
➜
Remote fetal well-being assessment is feasible and time-saving and results in high patient satisfaction. This novel paradigm of comprehensive remote maternal and fetal assessment is associated with important clinical, socioeconomic, and logistics advantages.
➜
Abstract: In light of the COVID-19 pandemic and other emergencies, telehealth has become vital for improving women’s health since it offers easy accessto medical care. This strategy makes virtual consultations, […]
➜
Adoption of telehealth technologies may improve the antenatal care experience for women and reducehealthcare expenditure without adversely impacting health outcomes for the mother or baby. More studies are war-ranted to confirm telehealth does not alter the risk of rare outcomes such as maternal or neonatal mortality.
➜
Self-examination using mobile systems for fetal ultrasound during pregnancy was generally acceptable for the pregnant women who participated. The analysis showed that the image quality was adequate for assessing amniotic fluid in most participants. Identification of fetal heartbeat and fetal facial profile was more challenging for the women. Further studies are needed to determine whether …
➜
The Pulsenmore ultrasound system is a feasible solution for remote sonographic fetal assessment. Further studies are needed to assess its role and impact in telehealth antenatal care and fetal surveillance.
➜
A look at how the COVID-19 pandemic has reshaped the prenatal treatment model for the benefit of patients and clinicians Colleen C. Denny, MD, and Steven R. Goldstein, MD, NCMP, CCD
➜
Nachrichten und Veranstaltungen
OMER, Israel, Feb 2, 2026 /PRNewswire/ — Pulsenmore Ltd. (NASDAQ, TASE: PLSM), a pioneer in home ultrasound technology, today announced a first commercial engagement with a medical center in the […]
➜
Pulsenmore and Clalit Health Services Launch First At-Home Follicular Monitoring Service for IVF and Fertility Preservation Commercial agreement potentially valued at approximately $4.5 million over five years following 18 month […]
➜
➜
RAMAT GAN, Israel, Nov. 3, 2025 /PRNewswire/ — Pulsenmore Ltd. (TASE: PULS), a pioneer in home ultrasound solutions, today announced that the U.S. Food and Drug Administration (FDA) has granted De Novo marketing authorization for the Pulsenmore ES, a home-use prenatal ultrasound platform that enables expectant mothers to perform guided scans at home interpreted by remote physicians.
➜
Pulsenmore (TASE: PULS), a pioneering provider of home-based ultrasound technology, has announced the renewal and expansion of its strategic partnership with Clalit Health Services, Israel's largest HMO. Over the next five years, Pulsenmore will supply 25,000 units of its advanced home ultrasound devices to support Clalit's commitment to accessible, high-quality prenatal care.
➜
Pulsenmore secured a commercial agreement with Sheba Medical Center, Tel Hashomer for remote patient monitoring of highrisk pregnancies using its’ home ultrasound solution. Sheba Medical Center, will utilize Pulsenmore's solution as part of its’ obstetrics department in the 'Sheba Beyond virtual hospital, offering top-quality medical services to insured individuals across various health funds. Full article …
➜
Pulsenmore (TASE:PULS), the world leader in self-scan ultrasound technology for at-home use and remote clinical diagnosis, announces its new clinical study collaboration with Michigan Medicine. The study will examine the ability to conduct a remote biophysical profile (BPP) test, by using the Pulsenmore home ultrasound with the guidance of a remote clinician, potentially reducing the clinical …
➜
Pulsenmore's CEO, Dr. Elazar Sonnenschein, has been named "Man of the Year" by Yedioth Ahronoth, the most renowned daily publication in Israel. The feature highlighted his achievements, showcasing his leadership and our collective efforts to make Pulsenmore a healthcare trailblazer.
➜
RAMAT GAN, Israel, Jan. 10, 2024 /PRNewswire/ — Pulsenmore (TASE: PULS), the global leader in self-scan ultrasound technology for home use, proudly announces the approval of its pioneering prenatal care solution by the Brazilian Health Regulatory Agency (ANVISA), marking a significant milestone in the company's international expansion.
➜
RAMAT GAN, Israel, Jan. 10, 2024 /PRNewswire/ — Pulsenmore (TASE: PULS), the global leader in self-scan ultrasound technology for home use, proudly announces the approval of its pioneering prenatal care solution by the Brazilian Health […]
➜
A new handheld, self-scanning ultrasound device that attaches to a smartphone allows pregnant women to see their baby in the womb at any time and in the comfort of their own home, without a visit to a hospital or clinic.
➜
Discover Israel's thriving innovation ecosystem and the latest technologies on the horizon in this special edition as is takes a deep dive into Israel's remarkable 75-year history of innovation, highlighting the country's key contributions to science and technology. One of the featured technologies is Pulsenmore, a remote ultrasound device that's revolutionizing at-home maternal fetal monitoring.
➜
Apr. 7, 2022, 08:00 AM RAMAT GAN, Israel, April 7, 2022 /PRNewswire/ — Home ultrasound developer Pulsenmore Ltd. (TASE: PULS) today announced the appointment of Hagar Spits as General Manager North America, as the company establishes U.S. operations […]
➜
Discover Israel's thriving innovation ecosystem and the latest technologies on the horizon in this special edition as is takes a deep dive into Israel's remarkable 75-year history of innovation, highlighting the country's key contributions to science and technology. One of the featured technologies is Pulsenmore, a remote ultrasound device that's revolutionizing at-home maternal fetal monitoring.
➜
Pulsenmore has announced partnership with GE Healthcare, including an agreement to invest up to $50 million in Pulsenmore and distribution of its’ products in key markets. This investment is aimed […]
➜
“In an office near Tel Aviv, a doctor checks the lungs of a Ukrainian refugee who is 2,000 kilometers away. It’s part of a new “virtual hospital” that has Israeli medical staff caring for people injured or displaced in Russia’s onslaught…. One of the systems in use, Pulsenmore, is a portable prenatal ultrasound device that …
➜
"This is the first time I know of that a humanitarian mission is adding extraordinary value to the first responders there,” says Dr. Galia Barkai, director general of Sheba Beyond…. using Pulsenmore’s prenatal ultrasound device that takes images at the point of care to be analyzed by Sheba OB/GYNs in Israel.
➜
Israeli home ultrasound developer Pulsenmore announced on Monday it has secured a multimillion-dollar contract to supply its portable device for self-examination of follicles in IVF (in vitro fertilization) and fertility preservation processes to Clalit Health Services, Israel’s largest healthcare organization.
➜
First purchase order for Pulsenmore's home ultrasound device for IVF processes
➜
Medika Life has featured Pulsenmore in first place in its watchlist for digital health companies impacting the healthcare industry in 2021. “This is a truly revolutionary device, enabling pregnant women to monitor fetal growth and development remotely.”
➜
Previous
Next
Downloads
Our recent webinar brought together leading experts in maternal-fetal health to explore the complex psychobiological effects of prenatal anxiety on both mother and child…
➜
We're absolutely thrilled by the vibrant energy following our recent webinar, a collaborative effort between Women's Health Innovation Series , Sheba Medical Center, Tel Hashomer, and Beilinson – Rabin Medical Center.
➜
Dr. Alex Peahl (University of Michigan) and Dr. Avi (Abraham) Tsur, MD (Sheba Medical Center, Tel Hashomer) discuss the shift towards more flexible, personalized, and hybrid hashtag#prenatalcare.
➜
Previous
Next
